GO:0140344 triglyceride transfer activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0140344 triglyceride transfer activity is a molecular function defined as directly binding a triglyceride and delivering it to an acceptor molecule or specific location.
• The microsomal triglyceride transfer protein (MTTP) is the best-characterized enzyme with this activity, and its ability to transfer triglycerides evolved to support lipoprotein assembly.
• Hepatic MTTP activity varies significantly among species, which has implications for translational studies of lipid metabolism.
• Triglyceride transfer activity is essential for the assembly and secretion of apolipoprotein B-containing lipoproteins, and its dysregulation is linked to diseases such as gallstone disease and lipid storage myopathies [5, 8].
• ORP8 (oxysterol-binding protein-related protein 8) acts as a lipophagy receptor that mediates lipid droplet turnover, connecting triglyceride transfer to autophagic pathways.
• Hypoxia-inducible lipid droplet-associated protein (HILPDA) induces DGAT1 and promotes lipid storage in hepatocytes, highlighting the interplay between triglyceride transfer and lipid droplet biology.
Description
Triglyceride transfer activity (GO:0140344) is a molecular function that enables the direct binding of a triglyceride molecule and its delivery to an acceptor molecule or a specific cellular location. This activity is fundamental to lipid metabolism, as it governs the movement of neutral lipids between membranes and lipoproteins, a process critical for energy storage and transport. The most extensively studied protein exhibiting this activity is the microsomal triglyceride transfer protein (MTTP), which plays a central role in the assembly of apolipoprotein B-containing lipoproteins in the liver and intestine [2, 3]. Understanding triglyceride transfer activity is essential for researchers investigating dyslipidemias, fatty liver diseases, and metabolic disorders, as it represents a key node in the regulation of systemic lipid homeostasis [5, 7]. The activity is not limited to MTTP; other proteins such as ORP8 and HILPDA have been implicated in related processes of lipid droplet turnover and lipid storage, expanding the functional landscape of this GO term [1, 4].
triglyceride transfer activity At A Glance
| GO ID | GO:0140344 |
|---|---|
| GO term | triglyceride transfer activity |
| Ontology | molecular_function |
| Synonym | triglyceride carrier activity |
| Major function | Directly binding to a triglyceride and delivering it either to an acceptor molecule or to a specific location. |
| Major protein | Microsomal triglyceride transfer protein (MTTP) |
| Related process | Lipoprotein assembly and secretion |
| Disease relevance | Gallstone disease, lipid storage myopathies, dyslipidemia |
What Is GO:0140344?
According to the Gene Ontology, triglyceride transfer activity (GO:0140344) is defined as the molecular function of directly binding to a triglyceride and delivering it either to an acceptor molecule or to a specific location. This definition encompasses the binding event and the subsequent transfer step, distinguishing it from simple lipid binding or transport activities that do not involve a direct delivery mechanism. The synonym 'triglyceride carrier activity' further emphasizes the role of the protein as a carrier that shuttles triglycerides between hydrophobic environments, such as from the endoplasmic reticulum membrane to nascent lipoprotein particles.
Why Is triglyceride transfer activity Important in Cell Biology?
Triglyceride transfer activity is critically important because it sits at the intersection of lipid absorption, lipoprotein assembly, and energy homeostasis. In the liver and intestine, MTTP-mediated triglyceride transfer is required for the lipidation of apolipoprotein B, a step that is indispensable for the secretion of very-low-density lipoprotein (VLDL) and chylomicrons [2, 3]. Without this activity, triglycerides accumulate in the cytosol, leading to steatosis and cellular dysfunction. Moreover, alterations in triglyceride transfer activity have been observed in human diseases such as gallstone disease, where increased hepatic MTTP activity is associated with bile acid synthesis changes. In lipid storage myopathies, defects in lipid droplet turnover and transfer contribute to muscle weakness and metabolic crises. Therefore, studying this activity provides mechanistic insights into both rare genetic disorders and common metabolic diseases.
• Essential for the assembly and secretion of apolipoprotein B-containing lipoproteins, including VLDL and chylomicrons.
• Regulates systemic lipid transport and energy distribution between tissues.
• Its dysregulation is linked to gallstone disease through increased hepatic MTTP activity.
• Implicated in lipid storage myopathies where lipid droplet turnover is impaired.
• Plays a role in lipid droplet metabolism and the development of steatosis.
• Connects to autophagic pathways via ORP8, a lipophagy receptor that mediates lipid droplet turnover.
• Modulated by HILPDA, which induces DGAT1 and promotes lipid storage in hepatocytes.
• Species-specific differences in MTTP activity impact the translation of animal models to human lipid metabolism.
• A target for therapeutic intervention in dyslipidemias and metabolic syndrome.
• Provides a biochemical marker for studying modified low-density lipoproteins and their immunoreactivity.
What Happens During triglyceride transfer activity?
Substrate Binding and Acceptor Recognition
In simple terms: The protein grabs a triglyceride molecule and finds a target to deliver it to.
The first step in triglyceride transfer activity involves the direct binding of a triglyceride molecule by a carrier protein such as MTTP. This binding occurs in a hydrophobic pocket that shields the neutral lipid from the aqueous environment. The protein then recognizes an acceptor molecule, which could be a nascent apolipoprotein B particle or a membrane lipid bilayer. This step is highly specific and is regulated by the availability of both the triglyceride substrate and the acceptor, as demonstrated by studies showing that MTTP acquires transfer activity during evolution to facilitate lipoprotein assembly.
Transfer and Delivery
In simple terms: The protein hands off the triglyceride to its destination.
Following acceptor recognition, the triglyceride is transferred from the carrier protein to the acceptor molecule. This delivery step is energetically driven by the concentration gradient and the hydrophobic environment of the acceptor. In the context of lipoprotein assembly, MTTP transfers triglycerides to apolipoprotein B, allowing the particle to expand and mature. The transfer activity is essential for the lipidation process, and its efficiency can be influenced by the lipid composition of the membranes involved.
Role in Lipid Droplet Turnover
In simple terms: Triglyceride transfer also helps break down fat droplets in cells.
Beyond lipoprotein assembly, triglyceride transfer activity is involved in lipid droplet turnover. ORP8 acts as a lipophagy receptor that mediates the interaction between lipid droplets and autophagosomes, facilitating the degradation of stored triglycerides. This process requires the recognition and transfer of triglycerides from lipid droplets to autophagic membranes, highlighting a broader role for triglyceride transfer activity in cellular lipid catabolism.
Regulation by Lipid Storage Proteins
In simple terms: Other proteins can turn up or down the fat transfer process.
HILPDA (hypoxia-inducible lipid droplet-associated protein) induces DGAT1, an enzyme that synthesizes triglycerides, thereby promoting lipid storage in hepatocytes. This suggests that triglyceride transfer activity is coupled with triglyceride synthesis and storage, and that proteins like HILPDA can modulate the overall flux through this pathway. The interplay between synthesis, transfer, and storage ensures that cells can adapt to changing energy demands and hypoxic conditions.
Key Genes Involved in GO:0140344 triglyceride transfer activity
The following genes and proteins are key players in triglyceride transfer activity and related lipid metabolic processes.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MTTP | Microsomal triglyceride transfer protein; transfers triglycerides to apolipoprotein B for lipoprotein assembly | Central to studies of VLDL secretion, abetalipoproteinemia, and gallstone disease [2, 3, 5] |
| ORP8 | Oxysterol-binding protein-related protein 8; acts as a lipophagy receptor mediating lipid droplet turnover | Links triglyceride transfer to autophagy and lipid droplet degradation |
| HILPDA | Hypoxia-inducible lipid droplet-associated protein; induces DGAT1 and promotes lipid storage | Regulates lipid storage in hepatocytes under hypoxia |
| DGAT1 | Diacylglycerol O-acyltransferase 1; catalyzes the final step of triglyceride synthesis | Induced by HILPDA; affects triglyceride availability for transfer |
| APOB | Apolipoprotein B; acceptor molecule for triglyceride transfer during lipoprotein assembly | Mutations cause familial hypobetalipoproteinemia; target for lipid-lowering therapies |
| PLIN2 | Perilipin 2; coats lipid droplets and regulates lipolysis | Marker of lipid droplet accumulation in steatosis |
| PNPLA2 | Patatin-like phospholipase domain-containing protein 2; triglyceride lipase | Mutations cause neutral lipid storage disease with myopathy |
| ABHD5 | Alpha/beta hydrolase domain-containing protein 5; coactivator of PNPLA2 | Mutations cause Chanarin-Dorfman syndrome, a lipid storage myopathy |
| CIDEC | Cell death-inducing DFFA-like effector c; promotes lipid droplet fusion | Involved in lipid droplet enlargement and storage |
| LIPE | Hormone-sensitive lipase; hydrolyzes stored triglycerides | Regulates lipolysis in adipose tissue |
| FABP4 | Fatty acid binding protein 4; transports fatty acids | Links fatty acid metabolism to triglyceride synthesis |
| SREBF1 | Sterol regulatory element-binding transcription factor 1; regulates lipogenic genes | Controls expression of MTTP and DGAT1 |
| PPARG | Peroxisome proliferator-activated receptor gamma; master regulator of adipogenesis | Affects lipid storage and triglyceride transfer capacity |
| INSIG1 | Insulin-induced gene 1; regulates SREBP processing | Modulates lipogenesis and triglyceride availability |
| SCAP | SREBP cleavage-activating protein; escorts SREBP to Golgi | Central to feedback regulation of lipid synthesis |
| LPL | Lipoprotein lipase; hydrolyzes triglycerides in lipoproteins | Determines tissue uptake of fatty acids from triglyceride-rich lipoproteins |
| APOC3 | Apolipoprotein C-III; inhibits lipoprotein lipase | Regulates plasma triglyceride levels; target for antisense therapies |
| ANGPTL4 | Angiopoietin-like 4; inhibits lipoprotein lipase | Modulates triglyceride clearance and lipid storage |
How Is triglyceride transfer activity Regulated?
Triglyceride transfer activity is regulated at multiple levels, including transcriptional control of MTTP by lipogenic transcription factors such as SREBP-1c, which responds to insulin and nutrient status. Additionally, the activity can be modulated by the availability of lipid substrates and acceptor molecules, as well as by post-translational modifications. HILPDA induces DGAT1 under hypoxic conditions, increasing triglyceride synthesis and potentially enhancing transfer activity. ORP8-mediated lipophagy provides a degradation route for lipid droplets, indirectly influencing the pool of triglycerides available for transfer. Furthermore, species-specific differences in MTTP activity suggest genetic and evolutionary regulation of this function.
triglyceride transfer activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MTTP | Gallstone disease; abetalipoproteinemia | Mttp knockout mouse; hepatic cell lines with MTTP overexpression |
| PNPLA2 | Neutral lipid storage disease with myopathy | Pnpla2 knockout mouse; patient-derived myotubes |
| ABHD5 | Chanarin-Dorfman syndrome | Abhd5 knockout zebrafish; lipid droplet imaging in fibroblasts |
| ORP8 | Lipid droplet turnover; autophagy | Osbpl8 knockout hepatocytes; lipophagy flux assays |
| HILPDA | Hepatic steatosis; hypoxia | Hilpda knockout mouse; hepatocyte-specific overexpression |
Gallstone Disease
Increased hepatic microsomal triglyceride transfer protein activity has been observed in patients with gallstone disease, alongside increased bile acid synthesis. This suggests that dysregulated triglyceride transfer may contribute to cholesterol gallstone formation by altering biliary lipid composition. Studying MTTP activity in gallstone disease models could reveal new therapeutic targets.
Lipid Storage Myopathies
Lipid storage myopathies are a group of disorders characterized by abnormal accumulation of lipid droplets in muscle fibers, often due to defects in triglyceride hydrolysis or transfer. Mutations in genes such as PNPLA2 and ABHD5 lead to impaired lipid breakdown, resulting in muscle weakness and exercise intolerance. Triglyceride transfer activity may be indirectly affected in these conditions, and research into lipid droplet turnover mechanisms is crucial for developing treatments.
Atherosclerosis and Dyslipidemia
MTTP-mediated triglyceride transfer is essential for the assembly of atherogenic lipoproteins such as VLDL and LDL. Elevated MTTP activity can lead to increased secretion of apolipoprotein B-containing lipoproteins, contributing to hypertriglyceridemia and atherosclerosis. Modifications of LDL by lipid transfer activity and triglyceride hydrolysis can alter its immunoreactivity, potentially impacting plaque formation. Therefore, targeting triglyceride transfer activity is a promising strategy for managing dyslipidemias.
Hepatic Steatosis
Impaired triglyceride transfer activity can lead to the accumulation of triglycerides in hepatocytes, causing steatosis. Lipid droplet metabolism is tightly linked to triglyceride transfer, and proteins such as HILPDA and ORP8 modulate this process [1, 4]. Understanding how triglyceride transfer is regulated in the liver may provide insights into non-alcoholic fatty liver disease (NAFLD) and its progression to steatohepatitis.
From triglyceride transfer activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of MTTP abolish triglyceride transfer and lipoprotein secretion? | MTTP knockout hepatoma cells (e.g., HepG2) or Mttp-/- mouse |
| How does a point mutation in MTTP affect its lipid transfer activity? | CRISPR knock-in of patient-derived MTTP mutations in cell lines |
| Can tagging MTTP with a fluorescent protein reveal its subcellular localization? | Knock-in of GFP-MTTP in hepatocytes |
| Does overexpression of HILPDA increase lipid storage? | Adenoviral overexpression of HILPDA in primary hepatocytes |
| What is the role of ORP8 in lipophagy? | ORP8 knockout cells with lipid droplet and autophagosome markers |
| How does PNPLA2 deficiency affect lipid droplet turnover? | PNPLA2 knockout myotubes or mouse model |
How to Study the triglyceride transfer activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Fluorescence lipid transfer assay | Rate of triglyceride transfer between donor and acceptor | Characterizing MTTP activity and mutants |
| BODIPY 493/503 staining | Lipid droplet number, size, and distribution | Assessing steatosis and lipid storage [1, 6] |
| Apolipoprotein B ELISA | Secretion of apoB-containing lipoproteins | Functional readout of MTTP activity [2, 3] |
| Western blot | Protein expression levels of MTTP, ORP8, HILPDA | Validating knockout or overexpression models [1, 4] |
| Autophagy flux assay | Lipophagy activity | Studying ORP8-mediated lipid droplet turnover |
| Triglyceride quantification kit | Cellular triglyceride content | Measuring lipid accumulation in steatosis models |
| CRISPR knockout | Gene function | Causal studies of triglyceride transfer genes [1, 4] |
| RNA-seq | Transcriptional changes | Identifying pathways regulated by triglyceride transfer activity |
Lipid Transfer Assays
Direct measurement of triglyceride transfer activity can be performed using fluorescence-based or radioactive lipid transfer assays. These assays typically involve donor and acceptor liposomes or lipoprotein particles, and the transfer of labeled triglycerides is monitored over time. Such methods are essential for characterizing MTTP activity and its mutants.
Lipid Droplet Imaging
Confocal microscopy with lipid droplet dyes (e.g., BODIPY 493/503) allows visualization of lipid droplet size, number, and distribution in cells. This method is widely used to assess the impact of triglyceride transfer activity on lipid storage and turnover [1, 6].
Lipoprotein Secretion Assays
The secretion of apolipoprotein B-containing lipoproteins can be measured by ELISA or Western blot of conditioned media from cultured hepatocytes. This provides a functional readout of MTTP-mediated triglyceride transfer activity [2, 3].
Genetic Knockout and Knock-in Models
CRISPR/Cas9-mediated knockout or knock-in of genes such as MTTP, ORP8, and HILPDA enables causal studies of triglyceride transfer activity in cell lines and animal models. These models help dissect the contribution of specific domains or residues to lipid transfer [1, 4].
How CRISPR Can Be Used to Study GO:0140344 triglyceride transfer activity
Knockout
CRISPR/Cas9 knockout of MTTP, ORP8, or HILPDA allows researchers to abolish triglyceride transfer activity and study the consequences on lipid metabolism, lipoprotein secretion, and lipid droplet dynamics [1, 2, 4]. For example, MTTP knockout cells fail to secrete apolipoprotein B, leading to intracellular lipid accumulation.
Point Mutation
Introducing patient-derived point mutations into MTTP or other genes via CRISPR knock-in can reveal how specific amino acid changes affect triglyceride transfer activity and protein stability. This approach is valuable for understanding the molecular basis of diseases like abetalipoproteinemia.
Knock-in
Knock-in of fluorescent tags (e.g., GFP) or epitope tags into endogenous loci enables real-time imaging and biochemical purification of triglyceride transfer proteins. This helps track their localization and interactions within cells [1, 4].
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of genes like HILPDA or MTTP can enhance triglyceride transfer activity, providing gain-of-function models to study lipid storage and secretion. Overexpression of HILPDA in hepatocytes increases lipid droplet formation and triglyceride content.
How EDITGENE Supports triglyceride transfer activity Research
Researchers studying triglyceride transfer activity-related genes often need to determine whether a candidate gene is causally involved in lipid metabolism, lipoprotein assembly, or lipid droplet turnover. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research, from generating knockout cell lines to creating precise point mutations and knock-in reporters.
Contact EDITGENE today to design your custom CRISPR model for triglyceride transfer activity research.
Frequently Asked Questions About triglyceride transfer activity
What is triglyceride transfer activity?
Triglyceride transfer activity (GO:0140344) is a molecular function where a protein directly binds a triglyceride and delivers it to an acceptor molecule or specific location, as defined by the Gene Ontology.
What genes are involved in triglyceride transfer activity?
Key genes include MTTP, which encodes the microsomal triglyceride transfer protein, as well as ORP8 and HILPDA, which regulate related lipid droplet processes [1, 2, 4].
How is triglyceride transfer activity measured?
It can be measured using fluorescence-based lipid transfer assays, lipoprotein secretion assays, and lipid droplet imaging with dyes like BODIPY [2, 6].
What diseases are associated with triglyceride transfer activity?
Dysregulation is linked to gallstone disease, lipid storage myopathies, atherosclerosis, and hepatic steatosis [5, 7, 8].
What is the role of MTTP in triglyceride transfer?
MTTP transfers triglycerides to apolipoprotein B during lipoprotein assembly, a critical step for VLDL and chylomicron secretion [2, 3].
How does ORP8 relate to triglyceride transfer?
ORP8 acts as a lipophagy receptor that mediates lipid droplet turnover, facilitating the degradation of stored triglycerides.
Can CRISPR be used to study triglyceride transfer activity?
Yes, CRISPR knockout, knock-in, and overexpression models allow researchers to dissect the function of genes like MTTP and ORP8 in lipid metabolism [1, 4].
What is the difference between triglyceride transfer and triglyceride synthesis?
Triglyceride synthesis is the enzymatic formation of triglycerides from diacylglycerol and fatty acyl-CoA, while transfer activity moves existing triglycerides between compartments or molecules [2, 4].
Which tissues express MTTP?
MTTP is primarily expressed in the liver and intestine, where it is essential for lipoprotein assembly [2, 3].
How does HILPDA affect triglyceride transfer?
HILPDA induces DGAT1 and promotes lipid storage in hepatocytes, indirectly influencing the pool of triglycerides available for transfer.
Conclusion
Triglyceride transfer activity (GO:0140344) is a fundamental molecular function that governs the movement of triglycerides within cells and between lipoproteins. Its central player, MTTP, is indispensable for lipoprotein assembly and systemic lipid transport, and its dysregulation contributes to a range of metabolic diseases [2, 5]. Emerging evidence implicates additional proteins such as ORP8 and HILPDA in related processes of lipid droplet turnover and storage, broadening the scope of this activity [1, 4]. Continued research using advanced CRISPR models and lipidomic approaches will further elucidate the mechanisms and therapeutic potential of targeting triglyceride transfer activity.
References
- 1. Pu M et al.. 2023. ORP8 acts as a lipophagy receptor to mediate lipid droplet turnover.. Protein Cell 14(9):653-667 PMID: 37707322
- 2. Rava P et al.. 2007. Acquisition of triacylglycerol transfer activity by microsomal triglyceride transfer protein during evolution.. Biochemistry 46(43):12263-74 PMID: 17924655
- 3. Bremmer DR et al.. 1999. Differences in activity of hepatic microsomal triglyceride transfer protein among species.. Comp Biochem Physiol A Mol Integr Physiol 124(2):123-31 PMID: 10629953
- 4. de la Rosa Rodriguez MA et al.. 2021. Hypoxia-inducible lipid droplet-associated induces DGAT1 and promotes lipid storage in hepatocytes.. Mol Metab 47:101168 PMID: 33465519
- 5. Castro J et al.. 2007. Increased activity of hepatic microsomal triglyceride transfer protein and bile acid synthesis in gallstone disease.. Hepatology 45(5):1261-6 PMID: 17464999
- 6. Khor VK et al.. 2013. Lipid droplet metabolism.. Curr Opin Clin Nutr Metab Care 16(6):632-7 PMID: 24100667
- 7. Viens L et al.. 1997. Effect of lipid transfer activity and triglyceride hydrolysis on apolipoprotein B immunoreactivity in modified low density lipoproteins.. J Lipid Res 38(6):1129-38 PMID: 9215541
- 8. Bruno C et al.. 2008. Lipid storage myopathies.. Curr Opin Neurol 21(5):601-6 PMID: 18769256
